Source: Clinical lymphoma myeloma & leukemia. Unidade: FM
Subjects: LEUCEMIA MIELOIDE AGUDA, EVENTO ADVERSO A MEDICAMENTO, MORTALIDADE, FARMACOTERAPIA, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA JUNIOR, Wellington Fernandes da e VELLOSO, Elvira D. R. P. e ROCHA, Vanderson. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen. Clinical lymphoma myeloma & leukemia, v. 18, n. 6, p. E255-E259, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clml.2018.03.001. Acesso em: 03 jun. 2024.APA
Silva Junior, W. F. da, Velloso, E. D. R. P., & Rocha, V. (2018). Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen. Clinical lymphoma myeloma & leukemia, 18( 6), E255-E259. doi:10.1016/j.clml.2018.03.001NLM
Silva Junior WF da, Velloso EDRP, Rocha V. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen [Internet]. Clinical lymphoma myeloma & leukemia. 2018 ; 18( 6): E255-E259.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.clml.2018.03.001Vancouver
Silva Junior WF da, Velloso EDRP, Rocha V. Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen [Internet]. Clinical lymphoma myeloma & leukemia. 2018 ; 18( 6): E255-E259.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.clml.2018.03.001
